Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. (Q53618262)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. |
scientific article |
Statements
Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study. (English)
George Wilding
1 reference
Roy S Herbst
Hope S Rugo
Glenn Liu
Teresa M McShane
Jeffrey L Evelhoch
Chaan Ng
Frederick Kelcz
Benjamin M Yeh
Fred T Lee
Chusilp Charnsangavej
John W Park
Edward A Ashton
Heidi M Steinfeldt
Yazdi K Pithavala
Steven D Reich
18 July 2005
23
24
5464-5473